In depth view into CLBS (Caladrius Biosciences) stock including the latest price, news, dividend history, earnings information and financials. 10, (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. &0183;&32;View Caladrius Biosciences, Inc. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. CLBS Stock Price Chart Interactive Chart > CLBS Price/Volume Stats.
Looking to buy Caladrius Biosciences stock? is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. &0183;&32;Price records that include history of low and high prices in caladrius stock price the period of 52 weeks can tell a lot about the stock’s existing status and the future performance.
93% higher than the lowest price point for the same timeframe. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. CLBS - Caladrius Biosciences Inc.
An important predictor of whether a stock price will go up is its track record of momentum. 56% over the next twelve months. 51% of Healthcare stocks. View live CALADRIUS BIOSCIENCES INC chart to track its stock's price action. Caladrius Biosciences, Inc.
The average price target is . Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. 09% of all US stocks.
Free current stock price quotes and data for Caladrius Biosciences Inc (CLBS). Current price . 1 day 2 caladrius stock price days 5 days 10 daysmonth 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart. TradingView India.
Wainwright 22nd Annual Global Investment Virtual Conference. On average, analysts give the stock a Strong Buy rating. Wall Street is positive on Caladrius Biosciences Inc (CLBS). 562, which means analysts expect the stock to gain by 175. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage. Our overall hedge fund sentiment score for CLBS is 58. Find the latest Caladrius Biosciences Inc. Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum.
The warrants have an exercise price equal to . Dive deeper with interactive charts and top stories of CALADRIUS BIOSCIENCES, INC. At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data,.
, through its subsidiary, PCT, LLC, a Caladrius Company. 110 Allen Road, 2nd Flr Basking Ridge, NJ 07920 Telephone: 908. &0183;&32;Find the latest Caladrius Biosciences, Inc. CLBS detailed stock quotes, stock data, Real.
Get the stock price and latest news for CLBS and start trading today with zero commissions. Get the latest Caladrius Biosciences, Inc. Under the purchase agreement, Caladrius has also issued to the investors unregistered warrants to purchase up to an aggregate of 1,042,425 shares of common stock. Caladrius Bio etfs funds price quote with latest real-time prices, charts, financials,. 76% if the CLBS share price touches on the median price of . was founded in 1980 and. 23% of Healthcare stocks.
View Caladrius stock / share price, financial statements, key ratios and more at Craft. com's stock comparison tool. NasdaqCM - NasdaqCM Real Time Price.
Presently, Caladrius Biosciences Inc. and changed its name to Caladrius Biosciences, Inc. Get real-time Caladrius Biosciences (CLBS) stock caladrius price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing. The number of analysts covering the stock of CLBS is greater than 14. Over the past six months, the relative strength of its shares against the market has been -36. Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum. BASKING RIDGE, N. 0625 per share, are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.
76%) Official Closing Price Updated: 1:44 PM EST, Add to My Watchlist. The company was founded on Septem and is headquartered in Basking Ridge, NJ. Information is provided 'as-is' and solely for info. 15% during the 52-week period from high price, and 110. Caladrius Biosciences (NASDAQ: CLBS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers.
This price target is based on 4 analysts offering 12 month price targets for Caladrius Biosciences in the last 3 months. Research news, charts, stock market performance and earnings. CALADRIUS caladrius stock price BIOSCIENCES INC 0HS8 Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.
(CLBS) to four other stocks with NASDAQ. Find market predictions, CLBS financials and market news. &0183;&32;Caladrius Bio (NQ: CLBS ) 1. Caladrius Biosciences to Present at H. 50 and a low forecast of . Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. comBASKING RIDGE, N.
Caladrius Biosciences Stock Price, Chart, Latest News, Technical Indicator and other information. About the Caladrius Biosciences, Inc. (CLBS) stock to its peers. 68%) At close: 4:00PM EDT. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today. The average price target represents a 604. However, in caladrius stock price so far, the stock price has risen by over 85%.
00:12:Free. 64 : 52-week high . Viemed Healthcare beats Caladrius Biosciences on 8 of the 13 factors compared between the two stocks. &0183;&32;CLBS has a greater upside potential (average analyst target price relative to current price) than 97. SG) stock quote, history, news and other vital information to help you with your stock trading and investing. Free forex prices, toplists, indices and lots more. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Caladrius Biosciences Inc's variance in analysts' estimates is less than 3.
View the latest CLBS stock quote and chart on MSN Money. &0183;&32;Caladrius Biosciences Inc (NASDAQ:CLBS)’s share price passed above its 200-day moving average during trading on Friday. Caladrius Biosciences price history, CLBS 1 day chart with daily, weekly, monthly prices and market capitalizations. Caladrius market cap is . 76% off the current price level respectively, although investors could be excited at the prospect of a +382. 480$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Online Stock Comparison - Compare Caladrius Biosciences, Inc.
The stock has a 200-day moving average of. &0183;&32;Caladrius Biosciences Inc (NASDAQ:CLBS) is not the most popular stock in this group but hedge fund interest is still above average. Caladrius Biosciences (CLBS) share price, charts, trades & the UK's most popular discussion forums.
&0183;&32;Learn about CLBS with our data and independent analysis including price, star rating, valuation, dividends, and financials. Caladrius Biosciences (CLBS) stock price, charts, trades & the US's most popular discussion forums. 50, with a high forecast of . 08, (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. 1 dag geleden &0183;&32;These price ends are 382. 58, indicating caladrius stock price that its stock price caladrius stock price is 58% more volatile than the S&P 500.
70% upside from the last price of . It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Comparatively, Viemed Healthcare has a beta of 1. Prices shown are actual historical values and are not adjusted for either splits or dividends. &0183;&32;Caladrius Biosciences has a beta of 1.
shares are logging -39. 00:02:Free. Let’s briefly compare Caladrius Biosciences, Inc. Shares of Caladrius Biosciences (NASDAQ:CLBS) have lost nearly two-thirds of their value over the past three years. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. , formerly NeoStem, Inc. CLBS investment & stock information.
Start a 14-day free trial to Morningstar Premium to. (CLBS) stock quote, history, news and other vital information to help you with your stock trading and investing. The average price target is . Overview Detailed Quote Charting Historical Prices. The company was formerly known as NeoStem, Inc. 52, indicating that its stock price is 52% more volatile than the S&P 500. Price trends tend to persist, so it's worth looking at them when it comes to a share like Caladrius Biosciences Inc.
-> Make money for yourself
-> Apportionment definition politics culture